Insights
Product updates from Medicup, plus healthcare technology news curated from trusted outlets — CDC, FDA, and leading health-tech publications.
A major industry event is focusing on a simple but revolutionary idea: putting the patient at the center of the healthcare ecosystem. Here’s why this shift to 'consumer-centered care' is so important for the future of your health.
A new startup called Outro has raised $7 million to help patients and doctors safely reduce or stop medications. Here's why this matters for the future of personalized care and telehealth.
From scheduling appointments to answering basic health questions, AI chatbots are becoming a common feature in digital healthcare. But what can they really do, and where do we draw the line?
For millions living in rural areas, accessing healthcare can be a significant challenge. Discover how telehealth is emerging as a powerful tool to connect patients with the care they need, regardless of their zip code.
For patients with type 2 diabetes, the risk of developing coronary artery disease is a serious concern. New research shows how an AI model can predict this risk using only routine lab results, paving the way for earlier, more personalized interventions.
Digital health tools promise unprecedented access to care, but a new analysis argues we must actively design them for justice and equity. Here’s what that means for the future of your healthcare.
A new startup is offering its AI-powered breast cancer risk prediction tool directly to consumers, bypassing the traditional clinic model. This raises important questions about the role of doctors in interpreting complex health data.
After the fall of Roe v. Wade, how can we understand the new landscape of abortion access? One researcher is using AI to analyze Reddit posts, providing a powerful new model for patient-centered digital health.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is implementing a new framework requiring continuous oversight of AI-powered medical devices throughout their lifecycle. This move aims to ensure safety and effectiveness as these technologies evolve.
The FDA has authorized the Libre Duo, a wearable device that continuously tracks both blood sugar (glucose) and ketone levels in people with diabetes aged 2 years and older. This marks a significant step forward in diabetes management.
The pharmaceutical industry's commercial teams are focusing on small efficiencies rather than the fundamental reinvention seen in digital health. Here's why that gap matters for patients and providers.
Industry leaders are already setting their sights on 2027's most important healthcare events. Here’s why the discussions at these conferences matter for the future of your care.
